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Biologic and technologic advances generated from The Human Genome Project are having a dramatic
impact on the expanding role of nurses in current health care practice. New genetic research needs to be
transformed rapidly into clinical protocols with recommendations for delivering care to targeted populations.
Nurses can contribute significantly, as part of an interdisciplinary approach, to translate genome-based knowledge
into benefits for health care and society. In this context, we describe a clinical-genetic investigation protocol, as
well nursing diagnosis, interventions and outcomes for clients with Turner Syndrome (TS) at risk for develop
gonadal tumors, due the presence of a normal or abnormal Y chromosome.
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ATENCIÓN DE ENFERMERÍA BASADA EN GENÓMICA
PARA LAS MUJERES CON SÍNDROME DE TURNER
Los avances biológicos y tecnológicos generados a partir del Proyecto Genoma Humano están teniendo
un impacto dramático en el extenso papel de las enfermeras en la práctica actual del cuidado de la salud.
Nuevas investigaciones genéticas necesitan ser transformadas rápidamente en protocolos clínicos con
recomendaciones para suministrar cuidados a las poblaciones necesitadas. Las enfermeras pueden contribuir
significantemente, como parte de un acercamiento interdisciplinario, traduciendo conocimientos basados en el
genoma en ventajas para el cuidado de la salud y la sociedad. En este contexto, describimos un protocolo de
investigación clínico-genético e también diagnósticos de enfermería, intervenciones y resultados para clientes
con Síndrome de Turner (TS) y riesgo de desarrollar tumores gonadales, debido a la presencia de un cromosoma
Y normal o anormal.
DESCRIPTORES: genética; diagnóstico de enfermería; atención de enfermería; consejo genético; Síndrome de
Turner
CUIDADO DE ENFERMAGEM BASEADO EM GENÔMICA
PARA MULHERES COM SÍNDROME DE TURNER
Os avanços biológicos e tecnológicos gerados a partir do Projeto Genoma Humano estão tendo um
impacto dramático na expansão do papel dos enfermeiros na prática atual do cuidado em saúde. As novas
pesquisas genéticas necessitam ser rapidamente transformadas em protocolos clínicos, com recomendações
para ministrar cuidados a populações alvo. Enfermeiros podem contribuir significantemente, como parte de
uma abordagem interdisciplinar, para traduzir o conhecimento baseado no genoma em benefícios para o
cuidado em saúde e para a sociedade. Neste contexto, nós descrevemos um protocolo de investigação clínico-
genético, assim como diagnósticos de enfermagem, intervenções e resultados para clientes com Síndrome de
Turner (ST) e risco de desenvolver tumores gonadais, devido à presença de um cromossomo Y normal ou
anormal.
DESCRITORES: genética; diagnóstico de enfermagem; cuidados de enfermagem; aconselhamento genético;
Síndrome de Turner
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NURSES IN THE GENOMIC ERA
With the recent completion of the genome
sequence and, thus, the successful conclusion of
mapping of the human genome, the first phase of the
Human Genome Project (HGP), we stand at the dawn
of the genomic era. These advances are
revolutionizing our understanding of the
pathophysiology of human diseases and health in
much greater detail than ever before. Genomic-based
approaches and resources are beginning to play a
key role in redefining our categorization of disease,
by making us focus on the biological pathways that
lead to them, and providing new approaches to
prevention and therapy(1).
Although much work remains to further our
understanding of how the genetic code carries out its
varied functions, the effect of the HGP on nursing and
health care is profound. Translating new human
genome research discoveries into clinical practice is
happening every day, and nurses in the genomic era
will be challenged to recognize genomic influences
on risks for diseases, develop and implement nursing
interventions, promote health and wellness, while
taking into account the appropriate clinical application
of genetic technology. Nurses are at the interface of
this translation and will increasingly care for individuals
and families who have a genetic condition or a genetic
component to their health or disease(1). Thus, there is
currently a growing acknowledgement that genetics
is not a peripheral specialty concerned only with rare
disorders, and of relevance only to nurses and other
health care professionals working within this specialist
field. There are major implications for nursing and
nurse education, as genetics increasingly permeates
all aspects of health care. While few nurses in the
foreseeable future will be directly involved with either
the science or the techniques of genetics, many are
already caring for people receiving some type of care
or therapy based on genetics. Now, genetics are
affecting nursing indirectly, but possibly in drastic ways
and, in the near future, genetics will be among the
areas of major importance for nursing(2). Many nursing
researchers have pointed that this is a high demand
arena for nursing practice in Brazil(3-5).
All nurses, regardless of their specialty or
practice area, have a role in delivering genetic health
care and managing genetic information. Understanding
how our clients regard themselves in light of genomic
health care is just a beginning step for nurses in being
able to make a difference, when providing nursing
care in the genomic era(4). Genetic information is
defined as any information about a client that identifies
heritable contributions to his health, or DNA changes
acquired during his lifetime. It can be found in genetics
tests results, family history and medical records. It is
unique and is distinguished from other medical
information because it is considered to be private and
linked to a person’s identity and sense of self, despite
its powerful implications for family members as well(6).
Therefore, this kind of information needs to be
transformed rapidly into clinical protocols with
recommendations for delivering care to targeted
populations, and nurses can contribute significantly,
as part of an interdisciplinary approach, to translate
genome-based knowledge into benefits for healthcare
and society(1,4).
In this context, we describe a clinical-genetic
investigation protocol, as well as nursing diagnosis,
interventions and outcomes for clients with Turner
Syndrome (TS) at risk for develop gonadal tumors,
due the presence of a normal or abnormal Y
chromosome.
TURNER SYNDROME AND GONADAL
TUMORS
Turner syndrome is defined as the
combination of short stature, gonadal dysgenesis
(streak gonads), typical phenotypic characteristics,
and urinary, cardiovascular, and skeletal
abnormalities, present in individuals with a female
phenotype, affecting 1 in 2500 live female births. In
40-60% of women with TS, the karyotypic anomaly
is a monosomy 45, X, but a variety of other
chromosome anomalies have been found including
mosaicism with a structurally normal or abnormal
second sex chromosome(7).
The presence of Y chromosome material in
individuals with TS is associated with the development
of a tumor called gonadoblastoma, which has
considerable malignant potential, with an estimated
risk around 25%. In 1987, the existence of the locus
GBY (Gonadoblastoma locus on Y chromosome) was
hypothesized, which predisposes the dysgenetic
gonads to develop gonadoblastoma. Today, the main
candidate gene is a probable oncogene known as TSPY.
Expression of this gene has been detected in
gonadoblastoma tissues. The incidence of Y
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chromosome sequences in individuals with TS has
been evaluated in several studies, and the introduction
of the molecular biology techniques, such as
Polymerase Chain Reaction (PCR), has revealed the
existence of hidden mosaics not detected at the
cytogenetic examination. According to the laboratory
methodology used, this frequency varied from 0% to
61%(7).
Currently, it is recommended to perform a
prophylactic gonadectomy in women with Y
chromosome material. However, recent
epidemiological studies have questioned the postulated
high incidence of gonadoblastoma in these cases(7).
The increasing interest in TS over the past
two decades has been motivated by the endeavor to
provide life-long support to the clients through
multidisciplinary care with quality of life.
CLINICAL-GENETIC INVESTIGATION
PROTOCOL
The Multidisciplinary Sex Determination and
Differentiation Outpatient Clinic at the Clinical Hospital
of the of Ribeirão Preto School of Medicine - University
of São Paulo, a tertiary care center, receives many
women with TS. The clinical-genetic investigation
protocol for these cases starts with the clinical
diagnosis of TS, during genetic counseling sessions,
provided by a multidisciplinary team composed by
physicians, geneticist nurse, psychologist and a social
worker, using a face-to-face communication process
to present information in the manner that best suits
each person needs. The written informed consent for
test is obtained from all individuals or their tutors, as
an important phase of the pretest education and
counseling. Verification of the individual understanding
of genetics contents is assessed verbal and
periodically during the subsequent counseling
sessions.
When a subject presents chromosomal
structural alterations or hidden mosaicism, the use of
conventional cytogenetic techniques can be ineffective,
so that molecular investigation is indicated. In this case,
DNA is extracted from peripheral blood leucocytes using
standard methods, and screened for the existence of
Y chromosome material through PCR, using four
different gene sequences spanning the entire
chromosome: SRY (Sex-determining Region of the Y,
located on Yp - short arm), AMGY and TSPY (located
on pericentomeric region), and DAZ (Deleted in
Azoospermia, located on Yq - long arm)(8) (Figure 1).
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Figure 1 - Schematic representation of Y chromosome
showing gene sequences studied by PCR(8)
The pathogenesis of gonadoblastoma and its
malignant potential is still rather obscure, but women
with TS, dysgenetic gonads and Y chromosome
material are at risk for this tumor. This risk has
previously been estimated to be almost 30%, and it
is directly proportional to age, being significantly
higher after puberty due to a lower degree of
virilization of the external genitalia and to the intra-
abdominal localization of the gonad(7). Gonadectomy
is generally recommended; however, this consensus
is questioned by some recent studies. They showed a
risk of 7–10% for the development of
gonadoblastoma, lower than the previously reported
figures, but it may still be unacceptably high in many
situations, and parents may still prefer prophylactic
gonadectomy. Detailed ultrasound examination of the
gonads at regular intervals, or even a magnetic
resonance imaging, may be sufficient to monitor some
Turner cases with Y chromosome material, especially
in cases where clients don’t want to have a surgery.
Therefore, gonadectomy is still the procedure of choice
if one wants to exclude malignancy with absolute
certainty(9).
Considering the relationship between
gonadoblastoma and the possibility of establishing the
X or Y origin of chromosomal fragments in individuals
with TS, the team uses the following approach for
cases with female or ambiguous genitalia, divided in
two groups according their karyotypes: (Group I)
Individuals with chromosome mosaicism - A) 45,X/
46,XX (normal or anomalous X) are followed clinically;
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B) 45,X/46,XY (normal or anomalous Y) are informed
about the risk of gonadal neoplasm and the need for
surgery, which can be performed at the time of
diagnosis. In this case, after surgery, they are
submitted to the same clinical treatment as the
individuals with 45,X/46,XX. (Group II) Subjects with
45,X with mosaicisms are monitored by ultrasound at
six month or one year intervals and, in some cases,
with magnetic resonance imaging, to detect possible
gonadal neoplasm not predicted by cytogenetic and
molecular analysis. In cases with 45,X karyotype
without mosaicism, we collect cheek cells and urine
in order to do a more sensitive PCR to study TSPY
sequences(9).
IMPLICATIONS FOR GENOMIC-BASED
NURSING PRACTICE
We report some aspects of a geneticist nurse
practice as a member of a Brazilian multidisciplinary
clinical and research team, carrying out the genetic
counseling process and genetic testing, using
molecular biology techniques for individuals with
Turner Syndrome at risk for gonadal tumors(8).
Genetic counseling has appeared in nursing
literature since the early 1960, when nurses’
psychosocial support and case-finding responsibilities
were emphasized(10). Genetic counseling became a
part of nursing standardized language when it was
included in the Nursing Interventions Classification(11),
where it is defined as an interactive helping process
focusing on assisting an individual, family or group,
manifesting or at risk for developing or transmitting
a birth defect or genetic condition. Genetic counseling
can also be defined as a communication and
educational process by which individuals and family
members receive information about the nature and
limitations of genetic tests, benefits, risks, and
meaning of tests results. Included within this process
are counseling and support concerning the implications
of information gained from genetic tests. Clients must
receive adequate information to make an informed
decision concerning their health and give informed
consent to undergo testing. It is a challenge to present
information that is often technically complex and
emotionally laden to individuals. Providing individuals
with clear, concise, complete and standardized
information is essential for informed decision-making.
Nurses may receive questions from their clients
concerning this process and must be able to address
those concerns(1).
The term genetic testing is now used in
common vocabulary and with little specificity, often
referring to very different applications of testing.
However, genetic test is the analysis of human DNA,
RNA, chromosomes, proteins, and certain metabolites
in order to detect heritable disease-related genotypes,
mutations, phenotypes or karyotypes for clinical
purposes. Genetic test can yield highly specific
information about future risk. Genetic information is
improving our understanding about the biology of
specific diseases, is increasingly used to more
precisely identify at risk individuals, to further
characterize diseases, to establish treatment tailored
to the genetic profile of the individuals and their
diseases(12).
Genetic testing has many benefits in terms
of indicating who may benefit from prevention, early
intervention and treatment to improve heath.
However, there remain many uncertainties, for
example the potential for tests results to provoke
anxiety, concerns regarding discrimination and social
stigmatization. All nurses in preparation for providing
genetic services should receive appropriate education
that includes foundational information on genetics and
genetic health care, as well as knowledge of the
implications and complexities of genetic testing, ability
to interpret results, and knowledge of the ethical,
social and psychological consequences of genetic
testing(1).
People with genetic conditions and their
families are at risk for many nursing diagnosis for
which nurses can apply components of genetic
counseling, but not all situations are reflected in the
current nursing diagnosis literature, and some
diagnoses are still in development stages. In Table 1,
we can see some nursing diagnoses for women with
TS. When delivering care to individuals with genetic
conditions or genetic related concerns, important
components of the nursing process are client teaching
and counseling interventions that promote the ability
of the client to cope with the situation (Table 2), and
nursing outcomes. An understanding of diagnoses and
outcomes is essential, however, to assist nurses in
becoming prepared to use genetic counseling as a
nurse intervention. As the role of genetic testing
increases in all areas of clinical practice, nurses will
need to have a good understanding of what genetic
tests are, the indications for their use, skills to support
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families throughout the testing process, awareness
of the influence of ethnicity, culture, and economics
in the client’s ability to use genetic information and
services. Even nurses without a huge knowledge in
genetics can incorporate specific aspects of the genetic
counseling process into their clinical practice. The
nursing focus is on the identification and prioritization
of strategies to promote a desirable outcome for clients
manifesting or at risk for developing a genetic
condition. According to Williams, nurses use several
nursing-sensitive outcomes to monitor the
effectiveness of genetic counseling in meeting
individuals’ psychosocial needs as related to the
genetics aspects of their health(10).
Table 1 - Nursing Diagnosis identified during genetic
counseling process for individuals with TS and a
normal or abnormal Y chromosome and/or their
families
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When we are assisting women with TS, we
expected that our clients enhance their knowledge
about TS and gonadoblastoma risk and are able to
participate in health care decisions about the proposed
clinical-genetic investigation protocol, as well as to
manifest health seeking behavior for available options
for surveillance and prevention, such as prophylactic
gonadectomy and clinical treatment, accepting health
status and also reproductive choices available for
individuals with TS. Acceptance of health status relates
to the clients’ ability to adjust to or come to terms
with their genetic health issues. Persons with TS have
a feminine gender identity, and lack of X or the
presence of a Y chromosome has no relationship to
inadequateness as a female, or lack of maternal
feelings. When appropriate, it can be explained to
the girl that she will be able to marry, enjoy sexual
relations, and that other reproductive options such
as adoption or receiving an egg donation are
available. In the older adolescents and young adults,
it is important to reemphasize the potential for a
satisfactory life. Indicators of the anxiety control
outcome can be used to measure a person’s anxiety
level, and relief from or exacerbation of anxiety
following genetic counseling and testing. The nurse
also monitors the individuals’ actions directed at
managing stressors for coping outcome. Maintaining
hope when facing uncertainty or loss is an important
outcome of genetic counseling that the nurse can
monitor through indicators of the hope outcome(13).
Table 2 - Key components of the genetic nursing
intervention for clients with TS and a normal or
abnormal Y chromosome
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Nurses are at the interface between
technology, clinical application of new genetics tests
and treatments, and the individuals and families who
make use of and are affected by new genetics
approaches to health and illness(1). Therefore, in all
practice settings, nurses are starting to participate in
the coordination of individual care and collaboration
with an interdisciplinary team of health professionals
to help clients receive the genetic information and
support their needs based on the fourfold
responsibilities laid on nurses practice: promoting
health, preventing illness, restoring health and
alleviating suffering(2). Nursing professionals’
involvement in research related to how individuals
and families come to understand their genetic
condition, share information within and outside the
family and redefine themselves in relationship to new
genetic information is needed(1).
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In conclusion, because of their unique and
holistic approach to care for their clients, nurses have
a wealth of knowledge, resources, and research ideas
to use in order to further enhance and improve clinical
care in the genomic age.
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